Krewel Meuselbach GmbH
Is this your company? Claim this profile
Drug Product
Company Overview
About
Krewel Meuselbach GmbH is a pharmaceutical CDMO offering comprehensive services.
Key Expertise
Specialized in Solid Dose Manufacturing, Oral Liquids, Topicals
Therapeutic Areas
Respiratory
Allergy
Quick Facts
HQ:Germany
Founded:2012
Employees:2,837
Capabilities & Services
Core Capabilities
- Biologics Drug Substance
- Biologics Manufacturing
- Formulation Development
Types of Organization
GMP Manufacturing
Quality Systems
Regulatory Support
Dosage Forms
Sterile Injectable
Production Scales
Phase III Clinical Trials
Commercial Scale
Clinical
Markets Served
North America
Europe
Regulatory Approvals
Drug Approval 4YT8WZ
PMDA · #APR-RET0BVXM · 2021-11-01
Drug Approval EVZCPV
FDA · #APR-JBHSSIZ7 · 2021-04-01
Certifications
ISO 9001:2015
International Organization for Standardization
Cert #: CERT-SX72W9KG
Issued: 2020-09-18
Expires: 2025-06-20
ISO 13485:2016
International Organization for Standardization
Cert #: CERT-KFNW9J9T
Issued: 2020-02-09
Expires: 2025-06-28
MHRA GMP
UK Medicines and Healthcare products Regulatory Agency
Cert #: CERT-33T5AYTX
Issued: 2020-02-28
Expires: 2025-04-28
Loading CDMO intelligence...
Key facts about Krewel Meuselbach GmbH
- Krewel Meuselbach GmbH is headquartered in Germany.
- Krewel Meuselbach GmbH was founded in 2012.
- Krewel Meuselbach GmbH has 2,837 employees.
- Krewel Meuselbach GmbH's capabilities include Biologics Drug Substance, Biologics Manufacturing and Formulation Development.
Find CDMOs like Krewel Meuselbach GmbH
Directory pages this company appears in, each with the full list of matching manufacturers.